新発性心房細動:発現,治療,結果における性差異
K H Humphries1, C R Kerr, S J Connolly
1Centre for Health Evaluation and Outcome Sciences, Vancouver, BC. karinh@cheos.ubc.ca
Circulation
|May 23, 2001
まとめ
心房細動 (AF) の高齢女性は,同様のリスクにもかかわらず,ウォルファリンなどの抗凝固剤を受ける可能性が低い. ワルファリンを服用している女性は出血のリスクが高く,AFの効果的な管理のためにより密接なモニタリングが必要である.
科学分野:
- 心臓病学 心臓病学
- クリニカル・メディシン 臨床医学
- 健康における性差異
背景:
- 冠動脈疾患における性差は十分に文書化されているが,心房動 (AF) の性差についてはあまり知られていない.
- これらの違いを理解することは,AF患者に合わせた検出と管理戦略を策定するために極めて重要です.
- 本研究では,新発症のAFの表情,治療,およびアウトカムにおける性に関する格差を調査しています.
研究 の 目的:
- 新発症した心房細動の呈現における性差を調べる.
- 性別に基づく治療アプローチの変動を分析する.
- 動を患っている男性と女性の臨床結果を比較する.
主な方法:
- 339人の女性と560人の男性を含む,カナダの心房細動記録 (CARAF) のデータを活用した.
- AF診断がECGで確認された後,4年以上にわたって参加者を追跡した.
- 病歴,臨床測定,心電図,心声,薬,介入に関するデータを収集したものです.
主要な成果:
- 女性は高齢で,症状が多く,男性と比較してAF中に心拍数が高かった.
- 高齢の女性は,ウォルファリンを老年男性より少なく,アスピリンを老年男性より多く受けた.
- ウォルファリンを服用した女性は,ウォルファリンを服用した男性よりも3.35倍頻繁に大出血を経験しました.
結論:
- 抗凝固薬は,男性と比較可能なリスクプロファイルにもかかわらず,AFの高齢女性では十分に使用されていません.
- ウォルファリンを服用している女性は,大出血のリスクが著しく高まります.
- ウォルファリンを投与しているAFの女性には,抗凝固剤の強度の注意深いモニタリングが不可欠です.
さらに関連する動画
10:18Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice
Published on: February 1, 2022
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
関連する概念動画
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...